OnKure Therapeutics, Inc.OKUREarnings & Financial Report
Nasdaq
OKUR Q3 2025 Key Financial Metrics
Revenue
$802.0K
Gross Profit
N/A
Operating Profit
$-15.5M
Net Profit
$-14.7M
Gross Margin
N/A
Operating Margin
-1932.8%
Net Margin
-1832.8%
YoY Growth
1922.7%
EPS
$-1.09
Financial Flow
OnKure Therapeutics, Inc. Q3 2025 Financial Summary
OnKure Therapeutics, Inc. reported revenue of $802.0K for Q3 2025, with a net profit of $-14.7M (-1832.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $802.0K |
|---|---|
| Net Profit | $-14.7M |
| Gross Margin | N/A |
| Operating Margin | -1932.8% |
| Report Period | Q3 2025 |
Income Statement
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Revenue | $204000 | $-44000 | $934000 | $802000 |
| YoY Growth | N/A | N/A | 357.8% | 1922.7% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Assets | $78.7M | $77.6M | $86.1M | $72.8M |
| Liabilities | $1.8M | $3.6M | $7.9M | $6.4M |
| Equity | $76.9M | $74.0M | $78.2M | $66.4M |
Cash Flow
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Operating CF | $-6.8M | $-2.3M | $-13.3M | $-13.0M |